NCT04451798Completed
Acute Impact of the Impella CP Assist Device in Pts. With Cardiogenic Shock on the Patients Hemodynamic
JENA Mechanical Assist Circulatory Support Trial-JENAMACS-hemodynamic
Source: ClinicalTrials.gov · Last updated 4 Aug 2026
Brief summary (registry, in English)
Prospective, monocentric open-label observational study for the assessment of acute hemodynamic effects following implantation of the IMPELLA CP cardiac support device
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- First submitted
- 1 Mar 2020
- Start date
- Dec 2016
- Primary completion date
- Aug 2026
- Lead sponsor
- University of Leipzig
- NCT number
- NCT04451798
What you commit to
- Study type: Interventional
- Planned participants: 20
- From Dec 2016 to the primary completion date, Aug 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Who the study is looking for
- Cardiogenic shock following acute MI or acute heart failure with
- systolic BP \< 90 mm Hg over \> 30 min or inotropes for support of cardiac output and BP with
- signs of left heart failure and pulmonary congestion
- and end-organ hypo perfusion with somnolence or cold, pale skin, or oliguria or serum lactate \>2 mmol/l
Age in the registry: 16 years to 91 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Jena Coordinator of this site? Confirm its status | Jena | Germany | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.